Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68788-8574

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68788-8574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure diagram of atorvastatin calcium showing the molecular arrangement of atoms, including fluorophenyl groups, hydroxyl groups, and calcium ions in the hydrated form with three water molecules.*

FDA Label Image

A Yellow Rectangular Object With Black Textdescription Automatically Generated (Container Label 40mg)

Atorvastatin Calcium Tablets 40 mg film-coated tablet label from Preferred Pharmaceuticals Inc. This prescription drug label includes dosage form details, manufacturer information (Recipharm Pharmaservices Pvt. Ltd.), and storage instructions. The label features bilingual dosing instructions in English and Spanish on a yellow background and a barcode alongside the company logo.*

FDA Label Image

Figure 1.jpg (Figure1)

A cumulative incidence line graph comparing Atorvastatin and Placebo over a period of up to 3.5 years. The y-axis represents cumulative incidence percentage ranging from 0 to 4%, and the x-axis shows time in years from 0 to 3.5. The graph includes hazard ratio (HR = 0.64 [0.50-0.83]) and a p-value (p = 0.0005). The Atorvastatin curve is solid, and the Placebo curve is dashed.*

FDA Label Image

Figure 2.jpg (Figure2)

A line chart showing cumulative hazard percentage over time comparing Atorvastatin and placebo. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage up to 15%. Two lines are shown: a dotted line for placebo and a solid line for Atorvastatin, with Atorvastatin demonstrating a lower cumulative hazard. The chart includes a hazard ratio (HR) of 0.63 (0.48-0.83) with a p-value of 0.001.*

FDA Label Image

Figure 3.jpg (Figure3)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over time between Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint in years (0-5), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2). The graph includes hazard ratio and p-value statistics indicating a comparison between the two dosages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.